Dengue Clinical Trial - This Study Will Describe the Burden of DENgue

See also
Status	Clinical Trial	Phase
Completed	`NCT05321264` - Educational Intervention to Promote Control Behaviors and Prevention of Dengue	N/A
Completed	`NCT01436396` - Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers	Phase 3
Completed	`NCT01391819` - Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children	N/A
Completed	`NCT03641339` - Defining Skin Immunity of a Bite of Key Insect Vectors in Humans	N/A
Completed	`NCT02833584` - Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in Adults	N/A
Completed	`NCT02433652` - Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2	Phase 1
Enrolling by invitation	`NCT02016027` - Pharmacological Effect of Carica Papaya Leaves Mother Tincture in Healthy Individuals Blood Parameter	Phase 1
Completed	`NCT01477671` - Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children	N/A
Recruiting	`NCT00377754` - Prospective Study of Infant Dengue	N/A
Recruiting	`NCT05919277` - A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires
Recruiting	`NCT04582474` - Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina Faso	N/A
Completed	`NCT01983553` - Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study
Completed	`NCT03803618` - Dengue Effectiveness Study in the Philippines
Active, not recruiting	`NCT05967455` - Homologous Re-infection With Dengue 1 or Dengue 3	Phase 1
Completed	`NCT03631719` - Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia
Recruiting	`NCT02606019` - The Use of Biomarkers in Predicting Dengue Outcome	N/A
Completed	`NCT02372175` - Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain	Phase 1
Active, not recruiting	`NCT01696422` - Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine	Phase 2
Completed	`NCT00993447` - Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America	Phase 2
Completed	`NCT00375726` - Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults	Phase 1

NCT number	NCT02766088
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Terminated
Phase	N/A
Start date	July 14, 2016
Completion date	December 14, 2018

This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms